GPT and metabolic dysfunction-associated steatotic liver disease: The lean NAFLD group had lower levels of liver and metabolic profiles, including alanine aminotransferase, platelet, gamma-glutamyl transferase, lipid profiles, and HOMA-IR, than the non-lean NAFLD group.